Modern Retina in print: The 4 issues of 2024

In an increasingly digital world, where news moves swiftly and time is crunched, digital reading has become an important part of staying up to date with any area of interest or focus. For the retina community, Modern Retina is proud to be a source of researched news, keeping you in the loop on the latest clinical trials and advancements in the field.

Alongside our digital stories, our print issues bring a level of depth and detailed research stories, largely written and submitted to us by retina specialists working in the field. These stories capture more nuance and explore areas of discussion in the retina space. After Modern Retina arrives in your mailbox, we also share these stories online, meaning that you can catch up with anything you may have missed from 2024 right now.

Spring 2024

In March, Modern Retina’s cover story the intersection of humanity and technology, especially in relation to clinical trials. In this issue, Pamela Ann Weber, MD, shared insights on discussing clinical trial participation with patients and how these studies can help patients obtain better visual outcomes and ease treatment burden.

See full list of stories from Spring 2024.

Summer 2024

June’s cover story was written by Brian Girschek, MD, FRCSC, FACS, and shared his experience with providing care to patients in rural areas through satellite clinics. In this article he noted that Proactive communication and leveraging advanced, yet reliable, technologies are key to maximizing efficiency and finding success.

See full list of stories from Summer 2024

Fall 2024

Arriving in mailboxes in September of 2024, the fall issue of Modern Retina featured a look at the social factors associated with diabetic retinopathy (DR) visit adherence. Arash Delavar, MD, MPH; Amer Fadel Alsoudi, MD; and Asad Loya, MD authored this piece as residents from Baylor College of Medicine in conjunction with Christina Y. Weng, MD, MBA. The article highlights the barriers that prevent some patients from receiving or continuing treatment for DR.

This article idea with submitted to the Modern Retina editorial team through our Resident Writer program, which aims to help residents draft and publish pieces on our website and in print. This program is set to continue in 2025. Residents looking to submit ideas or drafts for consideration can do so using the Resident Writer form.

See full list of stories from Fall 2024.

Winter 2024

In Modern Retina’s final issue of 2024, Dante Pieramici, MD, highlighted the current state of ocular drug delivery and the advancements that are in development to provide physicians with more options and to decrease the treatment burden for both patients adhering to treatment plans and the providers conducting the treatments.

See full list of stories from Winter 2024.

Coming in 2025

Modern Retina will continue to send print issues 4 times a year to US-based ophthalmologists. To subscribe ahead of our January/February mailing date, you can complete the form on the Ophthalmology Times website.